Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pharming Group N.V (PHAR) Current Leases: 2019-2024

Historic Current Leases for Pharming Group N.V (PHAR) over the last 6 years, with Dec 2024 value amounting to $2.9 million.

  • Pharming Group N.V's Current Leases rose 1.10% to $28.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.1 million, marking a year-over-year increase of 1.10%. This contributed to the annual value of $2.9 million for FY2024, which is 18.53% down from last year.
  • According to the latest figures from FY2024, Pharming Group N.V's Current Leases is $2.9 million, which was down 18.53% from $3.6 million recorded in FY2023.
  • In the past 5 years, Pharming Group N.V's Current Leases registered a high of $3.6 million during FY2023, and its lowest value of $2.0 million during FY2020.
  • Its 3-year average for Current Leases is $3.3 million, with a median of $3.5 million in 2022.
  • In the last 5 years, Pharming Group N.V's Current Leases spiked by 43.24% in 2022 and then fell by 18.53% in 2024.
  • Pharming Group N.V's Current Leases (Yearly) stood at $2.0 million in 2020, then grew by 23.29% to $2.4 million in 2021, then spiked by 43.24% to $3.5 million in 2022, then climbed by 4.36% to $3.6 million in 2023, then decreased by 18.53% to $2.9 million in 2024.